You are here

Medicare Part D

Medicare Part D in 2024: The Seven Largest Companies' Preferred Pharmacy Networks and the Coming Collapse of the PDP Market

Medicare Part D in 2024: The Seven Largest Companies' Preferred Pharmacy Networks and the Coming Collapse of the PDP Market

Drug Channels

Medicare Part D

Flag link:

Costliest Medicare drugs more than tripled in price since entering market: report

Costliest Medicare drugs more than tripled in price since entering market: report

Axios

Medicare Part D

Inflation Reduction Act

Flag link:

The Inflation Reduction Act: 10 Predictions About Market Access and Drug Channels

The Inflation Reduction Act: 10 Predictions About Market Access and Drug Channels

Drug Channels

Inflation Reduction Act

Medicare Part D

Flag link:

Small Pharmacies Walk Away from Medicare Part D’s 2023 Preferred Networks

Small Pharmacies Walk Away from Medicare Part D’s 2023 Preferred Networks

Drug Channels

Medicare Part D

Flag link:

New drug price law could help Part D enrollees who can't fill cancer treatments due to costs, White House says

New drug price law could help Part D enrollees who can't fill cancer treatments due to costs, White House says

Endpoints

Medicare Part D

Inflation Reduction Act

Flag link:

Many Medicare patients don't fill prescriptions for specialty drugs, study finds

Many Medicare patients don't fill prescriptions for specialty drugs, study finds

Beckers Hospital Review

Medicare Part D

specialty drugs

Flag link:

More biosimilar use could've saved Medicare and beneficiaries $84M in 2019, HHS OIG says

More biosimilar use could've saved Medicare and beneficiaries $84M in 2019, HHS OIG says

Endpoints

Medicare Part D

Flag link:

More Accountability Needed In Medicare Part D Plan Formulary Decision-Making

More Accountability Needed In Medicare Part D Plan Formulary Decision-Making

Forbes

Medicare Part D

Flag link:

Even More Independents Avoid 2020 Part D Preferred Pharmacy Networks

Even More Independents Avoid 2020 Part D Preferred Pharmacy Networks

Drug Channels

Medicare Part D

independent pharmacies

Flag link:

Preferred Pharmacy Networks Rebound in 2020 Medicare Part D Plans: Details on WellCare, CVS Health, Humana, Cigna, and More

Preferred Pharmacy Networks Rebound in 2020 Medicare Part D Plans: Details on WellCare, CVS Health, Humana, Cigna, and More

Drug Channels

Medicare Part D

preferred pharmacy networks

Flag link:

Explaining Medicare Part D's Success As A Byproduct Of Flat Voucher Subsidies

Explaining Medicare Part D's Success As A Byproduct Of Flat Voucher Subsidies

Forbes

Medicare Part D

Flag link:

Pharmacy benefit managers forwarded more than 99% of Part D rebates, GAO says

Pharmacy benefit managers forwarded more than 99% of Part D rebates, GAO says

Beckers Hospital Review

Medicare Part D

Flag link:

Medicare decides against tighter management of HIV drugs

Medicare decides against tighter management of HIV drugs

Biopharma Dive

Medicare Part D

Flag link:

White House, Congress considering killing Part D rebate rule, creating spending cap

White House, Congress considering killing Part D rebate rule, creating spending cap

BioCentury

Medicare Part D

Flag link:

Trump administration rebate proposal would not reduce list prices, CBO predicts

Trump administration rebate proposal would not reduce list prices, CBO predicts

BioCentury

Medicare Part D

Flag link:

Medicare predicts smaller increases in annual Part D drug spending

Medicare predicts smaller increases in annual Part D drug spending

BioCentury

Medicare Part D

Flag link:

The Road to 2020: Understanding the Regulatory Timeline for Part D Rebate Reform

The Road to 2020: Understanding the Regulatory Timeline for Part D Rebate Reform

Drug Channels

Medicare Part D

Flag link:

CMS demo could pave the path to eliminating Part D rebates

CMS demo could pave the path to eliminating Part D rebates

BioCentury

Medicare Part D

Flag link:

Specialty drug costs skyrocketed to $33B in Medicare Part D in 2015

Specialty drug costs skyrocketed to $33B in Medicare Part D in 2015

Biopharma Dive

Medicare Part D

specialty drugs

Flag link:

Medicare PBM rebate ban could migrate to private sector

Medicare PBM rebate ban could migrate to private sector

BioCentury

Medicare Part D

Flag link:

Pages